MMP9 and respiratory failure: This result suggests MMP9 may contribute to a reduced antibody generation, and is consistent with this protein being an indicator of respiratory failure (Ueland et al., 2020) and enhanced mortality risk in COVID-19 patients (C et al., 2021).